Name: Latest research reports of Abbott India Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Abbott India Ltd.
Rating: 5
Author: ICICI Securities Limited

Abbott India Ltd.

NSE: ABBOTINDIA | BSE: 500488 | ISIN: INE358A01014 | Industry: Pharmaceuticals
| Expensive Performer

29540.9000 -777.10 (-2.56%)

NSE Apr 02, 2025 15:31 PM

52W high on Mar 05, 2025

Volume: 8,629

Abbott India Ltd.

11 Feb 2022

29540.90

-2.56%

Abbott India

Buy: Abbott India Ltd.

Target

ICICI Securities Limited

Abbott's top 10 brands - (Mixtard, Thyronorm, Novomix, Udiliv, Duphaston) together posted revenue CAGR of ~7% MAT, December 2018-22 Abbott has 140+ brands in segments of women's health, gastroenterology,...

Number of FII/FPI investors decreased from 85 to 78 in Dec 2024 qtr